Recombinant coagulation factor VIIa - A novel haemostatic agent in scoliosis surgery?

European Spine Journal

Volumn 15, Issue 6, 2006, Pages 944-952

  Kolban, MacIej ^a   Balachowska Kosciolek, Ina ^b   Chmielnicki, Michal ^a  

^a Autonomous Public Clinical Hospital No 1   (Poland)

^b Intensive Care Unit   (Poland)

Author keywords

Bleeding; Haemostasis; RFVIIa; Scoliosis; Surgery

Indexed keywords

HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING PARAMETERS; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEMATOMA; HEMOSTASIS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OPERATION DURATION; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SCHOOL CHILD; SCOLIOSIS; SPINE FUSION; SPINE SURGERY; STANDARD; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; THROMBOEMBOLISM; TREATMENT INDICATION;

ADOLESCENT; ADULT; BLOOD COAGULATION; CASE-CONTROL STUDIES; CHILD; FACTOR VIIA; FEMALE; HEMOSTASIS, SURGICAL; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SAFETY; SCOLIOSIS; SPINAL FUSION;

EID: 33745038702     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-005-1004-5     Document Type: Article

References (45)

1. Aldouri M (2002) The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophilic patients. Pathophysiol Haemost Thromb 32(Suppl 1):41-46
2. Anand N, Idio FG, Remer S, Hoppenfeld S (1998) The effects of peri-operative blood salvage and autologous blood donation on transfusion requirements in scoliosis surgery. J Spinal Disord 11:532-534
3. Brecher ME, Monk T, Goodnough LT (1997) A standardized method for calculating blood loss. Transfusion 37:1070-1074
4. Chuansumrit A, Suwannuraks M, Sri-Udomporn N, Pongtanakul B, Worapongpaiboon S (2003) Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagul Fibrinolysis 14:187-190
5. Cole JW, Murray DJ, Snider RJ et al (2003) Aprotinin reduces blood loss during spinal surgery in children. Spine 28:2482-2485
6. Copley LAB, Richards BS, Safavi FZ, Newton PO (1999) Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine 24:219-224
7. d'Oiron R, Menart C, Trzeciak MC, et al (2000) Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 83:644-647
8. Eikelboom JW, Bird R, Blythe D, et al (2003) Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 14:713-717
9. Florentino-Pineda I, Blakemore LC, Thompson GH, et al (2001) The effect of E-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion. Spine 26:1147-1151
10. Friederich PW, Henny CP, Messelink EJ, et al (2003) Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 361:201-205
11. Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anesthesiology 58:277-280
12. Guay J, Haig M, Lortie L, Guertin M-C, Poitras B (1994) Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 41:775-781
13. Guillet B, Pinganaud C, Proulle V, Dreyfus M, Lambert T (2002) Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII. Thromb Haemost 88:698-699
14. Hedner U (2000) NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinolysis 11:107-111
15. Hoffman M (2003) A cell-based model of coagulation and the role of factor VIIa. Blood Rev 17:S1-S5
16. Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH (2004) The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion 44:1562-1566
17. Hunault M, Bauer KA (2000) Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 26:401-405
18. Kannan S, Meert KL, Mooney JF, Hillman-Wiseman C, Warrier I (2002) Bleeding and coagulation changes during spinal fusion surgery: a comparison of neuromuscular and idiopathic scoliosis patients. Pediatr Crit Care Med 3:364-369
19. Letts M, Pang E, D'Astrous J, et al (1998) The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine 23:475-478
20. Levi M, Peters M, Büller HR (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 33:883-890
21. Martinowitz U, Kenet G, Segal E, et al (2001) Recombinant activated rFVIIa for adjunctive haemorrhage control in trauma. J Trauma 51:431-438
22. Mayer SA, Brun NC, Begtrup K, et al (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777-786
23. McCall RE, Bilderback KK (1997) Use of intravenous premarin to decrease postoperative blood loss after pediatric scoliosis surgery. Spine 22:1394-1397
24. McNeill TW, DeWald RL, Kuo KN, Bennett EJ, Salem MR (1974) Controlled hypotensive anesthesia in scoliosis surgery. J Bone Joint Surg Am 56:1167-1172
25. Mercuriali F, Inghilleri G (1996) Proposal of an algorithm to help the choice of best transfusion strategy. Curr Med Res Opin 13:465-478
26. Monroe DM, Hoffman M, Oliver JA, Roberts HR (1998) A possible mechanism of action of factor VIIa independent of tissue factor. Blood Coagul Fibrinolysis 9:S15-S20
27. Mullighan CG, Rischbieth A, Duncan EM, Lloyd JV (2004) Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven). Blood Coagul Fibrinolysis 15:347-351
28. Murray DJ, Forbes RB, Titone MB, Weinstein SL (1997) Transfusion management in pediatric and adolescent scoliosis surgery. Spine 22:2735-2740
29. Murray DJ, Pennell BJ, Weinstein SL, et al (1995) Packed red cells in acute blood loss: Dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 80:336-342
30. Park KS, Lim YJ, Do SH (2004) Combined use of autologous transfusion techniques to avoid allogeneic transfusion in spinal fusion surgery with instrumentation. Int J Clin Pract 58:260-263
31. Park P, Fewel ME, Garton HJ, Thompson BG, Hoff JT (2003) Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 53:34-39
32. Patel NJ, Patel BS, Paskin S, Laufer S (1985) Induced moderate hypotensive anesthesia for spinal fusion and Harrington-rod instrumentation. J Bone Joint Surg Am 67:1384-1387
33. Peerlinck K, Vermylen J (1999) Acute myocardial infarction following administration of recombinant activated factor VII (NovoSeven) in a patient with haemophilia A and inhibitor. Thromb Haemost 82:1775-1776
34. Peleg I, Eldor A, Kahane I, et al (1989) Altered structural and functional properties of myosins, from platelets of idiopathic scoliosis patients. J Orthop Res 7:260-265
35. Phillips WA, Hensinger RN (1988) Control of blood loss during scoliosis surgery. Clin Orthop 229:88-93
36. Poon MC, Demers C, Jobin F, Wu JW (1999) Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 94:3951-3953
37. Poon MC, d'Oiron R, Hann I, et al (2001) Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 38:21-25
38. Renkens KL Jr, Payner TD, Leipzig TJ, et al (2001) A multicenter, prospective, randomized trial evaluating a new haemostatic agent for spinal surgery. Spine 26:1645-1650
39. Roberts HR, Monroe DM III, Hoffman M (2004) Safety profile of recombinant factor VIIa. Sem Hematol 41(Suppl 1):101-108
40. Sabel M, Stummer W (2004) The use of local agents: Surgicel and Surgifoam. Eur Spine J 13(Suppl 1):S97-S101
41. Scharrer I (1999) Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 5:253-259
42. Uden A, Nilsson IM, Willner S (1980) Collagen-induced platelet aggregation and bleeding time in adolescent idiopathic scoliosis. Acta Orthop Scand 51:773-777
43. Wang YR, Liu YC, Chung NC, et al (2003) Inferior vena cava tear during posterior spinal fusion surgery. Acta Anaesthesiol Sin 41:89-92
44. Yarom R, Muhlrad A, Hodges S, Robin GC (1980) Platelet pathology in patients with idiopathic scoliosis: ultrastructural morphology, aggregations, x-ray spectrometry, and biochemical analysis. Lab Invest 43:208-216
45. Zheng F, Cammisa FP, Sandhu HS, Girardi FP, Khan SN (2002) Factors predicting hospital stay, operative time, blood loss, and transfusion in patients undergoing revision posterior lumbar spine decompression, fusion, and segmental instrumentation. Spine 8:818-824